PALB2 and neoplasm: We performed panel testing in tumour samples from Portugal (n = 8) and WES in tumour samples from Colombia (n = 4) and Mexico (n = 3) in carriers of P/LP variants in ATM (nine cases), TP53 (two cases), RAD51D (two cases), PALB2 (one case), and MLH1 (one case) (Fig. 2, Supplementary Table S10).